The use of a second reporter plasmid as an internal standard to normalize luciferase activity in transient transfection experiments may lead to a systematic error

Tamás Huszár, I. Mucsi, Tamás Terebessy, András Masszi, Sarolta Adamkó, Csaba Jeney, L. Rosivall

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

β-galactosidase reporter plasmids containing different viral or minimal promoters are commonly used to correct variable transfection efficiencies in transient transfection experiments. The transcriptional activity of these promoters is thought to be stable under most circumstances. To determine if expression of β-galactosidase from the commonly used β-galactosidase plasmids remains stable upon stimulation of the cells with agonists we performed transient transfection experiments. CHO cells stably expressing the rat AT1A receptor were transfected with RSVβ- or CMVβ- or pTKβ plasmids alone or together with a reporter construct in which luciferase transcription is driven by the c-fos promoter. Luciferase and/or β-galactosidase activity was measured from the lysate of cells treated with angiotensin II or serum. We found that agonists increased the transcriptional activity of the different β-galactosidase plasmids. The effect of angiotensin II and serum was different on the different promoters. Finally, cotransfection of other plasmids also modulated β-galactosidase activity. These agonist induced variations of β-galactosidase activity may influence the analysis and interpretation of the results in a systematic manner. Consequently we conclude that the use of a second reporter system to control for transfection efficiency in certain types of experiments may lead to a systematic error and is questionable as a general procedure.

Original languageEnglish
Pages (from-to)251-258
Number of pages8
JournalJournal of Biotechnology
Volume88
Issue number3
DOIs
Publication statusPublished - Jul 12 2001

Fingerprint

Galactosidases
Systematic errors
Luciferases
Transfection
Plasmids
Experiments
Angiotensin II
CHO Cells
Transcription
Serum
Rats

Keywords

  • β-Galactosidase vectors
  • Internal standard
  • Transient transfection

ASJC Scopus subject areas

  • Biotechnology

Cite this

The use of a second reporter plasmid as an internal standard to normalize luciferase activity in transient transfection experiments may lead to a systematic error. / Huszár, Tamás; Mucsi, I.; Terebessy, Tamás; Masszi, András; Adamkó, Sarolta; Jeney, Csaba; Rosivall, L.

In: Journal of Biotechnology, Vol. 88, No. 3, 12.07.2001, p. 251-258.

Research output: Contribution to journalArticle

@article{466759eaa00644c8a1e5aa9828d408da,
title = "The use of a second reporter plasmid as an internal standard to normalize luciferase activity in transient transfection experiments may lead to a systematic error",
abstract = "β-galactosidase reporter plasmids containing different viral or minimal promoters are commonly used to correct variable transfection efficiencies in transient transfection experiments. The transcriptional activity of these promoters is thought to be stable under most circumstances. To determine if expression of β-galactosidase from the commonly used β-galactosidase plasmids remains stable upon stimulation of the cells with agonists we performed transient transfection experiments. CHO cells stably expressing the rat AT1A receptor were transfected with RSVβ- or CMVβ- or pTKβ plasmids alone or together with a reporter construct in which luciferase transcription is driven by the c-fos promoter. Luciferase and/or β-galactosidase activity was measured from the lysate of cells treated with angiotensin II or serum. We found that agonists increased the transcriptional activity of the different β-galactosidase plasmids. The effect of angiotensin II and serum was different on the different promoters. Finally, cotransfection of other plasmids also modulated β-galactosidase activity. These agonist induced variations of β-galactosidase activity may influence the analysis and interpretation of the results in a systematic manner. Consequently we conclude that the use of a second reporter system to control for transfection efficiency in certain types of experiments may lead to a systematic error and is questionable as a general procedure.",
keywords = "β-Galactosidase vectors, Internal standard, Transient transfection",
author = "Tam{\'a}s Husz{\'a}r and I. Mucsi and Tam{\'a}s Terebessy and Andr{\'a}s Masszi and Sarolta Adamk{\'o} and Csaba Jeney and L. Rosivall",
year = "2001",
month = "7",
day = "12",
doi = "10.1016/S0168-1656(01)00277-2",
language = "English",
volume = "88",
pages = "251--258",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - The use of a second reporter plasmid as an internal standard to normalize luciferase activity in transient transfection experiments may lead to a systematic error

AU - Huszár, Tamás

AU - Mucsi, I.

AU - Terebessy, Tamás

AU - Masszi, András

AU - Adamkó, Sarolta

AU - Jeney, Csaba

AU - Rosivall, L.

PY - 2001/7/12

Y1 - 2001/7/12

N2 - β-galactosidase reporter plasmids containing different viral or minimal promoters are commonly used to correct variable transfection efficiencies in transient transfection experiments. The transcriptional activity of these promoters is thought to be stable under most circumstances. To determine if expression of β-galactosidase from the commonly used β-galactosidase plasmids remains stable upon stimulation of the cells with agonists we performed transient transfection experiments. CHO cells stably expressing the rat AT1A receptor were transfected with RSVβ- or CMVβ- or pTKβ plasmids alone or together with a reporter construct in which luciferase transcription is driven by the c-fos promoter. Luciferase and/or β-galactosidase activity was measured from the lysate of cells treated with angiotensin II or serum. We found that agonists increased the transcriptional activity of the different β-galactosidase plasmids. The effect of angiotensin II and serum was different on the different promoters. Finally, cotransfection of other plasmids also modulated β-galactosidase activity. These agonist induced variations of β-galactosidase activity may influence the analysis and interpretation of the results in a systematic manner. Consequently we conclude that the use of a second reporter system to control for transfection efficiency in certain types of experiments may lead to a systematic error and is questionable as a general procedure.

AB - β-galactosidase reporter plasmids containing different viral or minimal promoters are commonly used to correct variable transfection efficiencies in transient transfection experiments. The transcriptional activity of these promoters is thought to be stable under most circumstances. To determine if expression of β-galactosidase from the commonly used β-galactosidase plasmids remains stable upon stimulation of the cells with agonists we performed transient transfection experiments. CHO cells stably expressing the rat AT1A receptor were transfected with RSVβ- or CMVβ- or pTKβ plasmids alone or together with a reporter construct in which luciferase transcription is driven by the c-fos promoter. Luciferase and/or β-galactosidase activity was measured from the lysate of cells treated with angiotensin II or serum. We found that agonists increased the transcriptional activity of the different β-galactosidase plasmids. The effect of angiotensin II and serum was different on the different promoters. Finally, cotransfection of other plasmids also modulated β-galactosidase activity. These agonist induced variations of β-galactosidase activity may influence the analysis and interpretation of the results in a systematic manner. Consequently we conclude that the use of a second reporter system to control for transfection efficiency in certain types of experiments may lead to a systematic error and is questionable as a general procedure.

KW - β-Galactosidase vectors

KW - Internal standard

KW - Transient transfection

UR - http://www.scopus.com/inward/record.url?scp=0035850254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035850254&partnerID=8YFLogxK

U2 - 10.1016/S0168-1656(01)00277-2

DO - 10.1016/S0168-1656(01)00277-2

M3 - Article

VL - 88

SP - 251

EP - 258

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

IS - 3

ER -